Overview
Living with Gout? Join a No-Cost Gout Research Study
We are currently enrolling participants for a clinical trial exploring an investigational treatment for gout. Researchers are studying a potential new, non-opioid treatment for people with gout, and your participation is critical to helping discover new ways to potentially manage this condition.
Make a Difference
Your participation could help researchers develop future treatments for gout. Play a crucial role in advancing research and help make a difference for yourself and others.
See if You Qualify
Ready to make a difference? Take our quick prescreener now and see if you qualify for our research study on gout.
About this Study
Study to Evaluate the Efficacy and Safety of Dotinurad Compared with Allopurinol in Adult Participants with Tophaceous Gout
Tophaceous Gout (or Chronic Gout)
If gout goes untreated or is poorly managed for a long time, it can progress to a more severe stage in gout. In this stage, the uric acid crystals have built up so much that they form large, visible, chalky-white or yellowish nodules under the skin called tophi.
Who Can Join
- 18-75 years old
- Diagnosed with gout for at least 1 year
- Had at least 2 flares in the past 12 months
- Must have tophi (tophaceous gout)
- Currently taking allopurinol (≥300 mg/day or ≥200 mg/day with kidney issues) up to 600 mg/day for at least 3 months prior to screening
- BMI is between 18.5 to 45
- No heart events, kidney stones, or major illnesses within 1 year
- No gastrointestinal disorder affecting absorption
- No cancer within the last 5 years, except for skin cancer.
*Other conditions may apply
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this study may be right for you.
What to Expect
Study Duration:
- Up to 20 months total participation
Study Visits:
- Up to 20 site visits
Compensation:
Participants may receive compensation up to $1075